The challenge
- A mid-size Life Sciences organization, who recently launched an infusible CNS product, set a goal of having 80%-90% of interested infusion centers be “Infusion Ready” within 1 year of launch.
- The initial “focus” list of infusion centers proved to be error prone, reducing the effectiveness of the clinical educators tasked with driving “infusion readiness”.
- The client needed revamped target lists in existing territories to accelerate infusion readiness ahead of a clinical educator field team expansion.
Our approach and solution
- Review current state Target List to understand the original targeting methodology.
- Utilize deep expertise to build a refined targeting methodology from in-house proprietary data sources, client data and publicly available sources that addressed current targeting challenges.
- Develop and deploy new focus lists based on patient volume, population demographics and educator drive-time.
The results
- Within 8 weeks, Propensity4 delivered refined targeting lists to existing and newly launched clinical educators in the field.
- The output was so well received, the commercial organization explored expanding the Propensity4 methodology across the Sales organization.
Infusion center focus accounts delivered:
|
>1.3k |
78% |
| of “focus” accounts are segmented as high in patient or specialist counts or both |
of “focus” accounts have product available and are the highest priority for Infusion readiness |
Learn more about our work.
Jump to a slide with the slide dots.
Welcome to the Team: Isabelle Amick, Senior Director of Data Science
We’re thrilled to announce that Isabelle Amick has joined Propensity4 as our new Senior Director of Data Science!
Read morePowering a U.S. Launch: Building a Commercial Infrastructure from the Ground Up
End-to-end US launch support for EU client’s dry eye device—from KAM team and CRM setup to data analytics, targeting, and incentive strategy.
Read more
Chris Savage
Improve your forecast with “bottom-up” methodologies
This blog explores how “bottom-up” forecasting, particularly Most Probable Forecasting (MPF), enhances pharmaceutical brand planning.
Read morePredictive Patient Engagement Program
Personalized patient engagement boosted therapy adherence with AI-driven insights, risk scoring, and tailored support recommendations.
Read more
Isabelle Amick
Rare-disease patient finding: Identifying the “right” patients at the “right” time.
Accelerating rare disease diagnosis through data-driven patient finding and predictive modeling to connect patients with the right HCPs faster.
Read more